Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma

Abnormal circulation in solid tumors results in hypoxia, which modulates both tumor intrinsic malignant properties as well as anti-tumor immune responses. Given the importance of hypoxia in glioblastoma (GBM) biology and particularly in shaping anti-tumor immunity, we analysed which immunomodulatory...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohapatra, Soumya Ranjan (Author) , Sadik, Ahmed (Author) , Tykocinski, Lars-Oliver (Author) , Dietze, Jørn (Author) , Poschet, Gernot (Author) , Heiland, Ines (Author) , Opitz, Christiane (Author)
Format: Article (Journal)
Language:English
Published: 04 December 2019
In: Frontiers in immunology
Year: 2019, Volume: 10
ISSN:1664-3224
DOI:10.3389/fimmu.2019.02762
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fimmu.2019.02762
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2019.02762/full
Get full text
Author Notes:Soumya R. Mohapatra, Ahmed Sadik, Lars-Oliver Tykocinski, Jørn Dietze, Gernot Poschet, Ines Heiland and Christiane A. Opitz

MARC

LEADER 00000caa a2200000 c 4500
001 1694253449
003 DE-627
005 20220818033607.0
007 cr uuu---uuuuu
008 200408s2019 xx |||||o 00| ||eng c
024 7 |a 10.3389/fimmu.2019.02762  |2 doi 
035 |a (DE-627)1694253449 
035 |a (DE-599)KXP1694253449 
035 |a (OCoLC)1341313967 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mohapatra, Soumya Ranjan  |e VerfasserIn  |0 (DE-588)1181830699  |0 (DE-627)166240798X  |4 aut 
245 1 0 |a Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma  |c Soumya R. Mohapatra, Ahmed Sadik, Lars-Oliver Tykocinski, Jørn Dietze, Gernot Poschet, Ines Heiland and Christiane A. Opitz 
246 3 3 |a Hypoxia inducible factor 1alpha inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma 
264 1 |c 04 December 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist alpha als griechischer Buchstabe dargestellt 
500 |a Gesehen am 08.04.2020 
520 |a Abnormal circulation in solid tumors results in hypoxia, which modulates both tumor intrinsic malignant properties as well as anti-tumor immune responses. Given the importance of hypoxia in glioblastoma (GBM) biology and particularly in shaping anti-tumor immunity, we analysed which immunomodulatory genes are differentially regulated in response to hypoxia in GBM cells. Gene expression analyses identified the immunosuppressive enzyme tryptophan-2,3-dioxygenase (TDO2) as the second most downregulated gene in GBM cells cultured under hypoxic conditions. TDO2 catalyses the oxidation of tryptophan to N-formyl kynurenine, which is the first and rate-limiting step of Trp degradation along the kynurenine pathway (KP). In multiple GBM cell lines hypoxia reduced TDO2 expression both at mRNA and protein levels. The downregulation of TDO2 through hypoxia was reversible as re-oxygenation rescued TDO2 expression. Computational modelling of tryptophan metabolism predicted reduced flux through the KP and lower concentrations of kynurenine and its downstream metabolite 3-hydroxyanthranilic acid under hypoxia. Metabolic measurements confirmed the predicted changes, thus demonstrating the ability of the mathematical model to infer tryptophan metabolite concentrations. Moreover, we identified hypoxia inducible factor 1α (HIF1α) to regulate TDO2 expression under hypoxic conditions, as the HIF1α-stabilising agents dimethyloxalylglycine (DMOG) and cobalt chloride reduced TDO2 expression. Knockdown of HIF1α restored the expression of TDO2 upon cobalt chloride treatment, confirming that HIF1α controls TDO2 expression. To investigate the immunoregulatory effects of this novel mechanism of TDO2 regulation, we co-cultured isolated T cells with TDO2-expressing GBM cells under normoxic and hypoxic conditions. Under normoxia TDO2-expressing GBM cells suppressed T cell proliferation, while hypoxia restored the proliferation of the T cells, likely due to the reduction in kynurenine levels produced by the GBM cells. Taken together, our data suggest that the regulation of TDO2 expression by HIF1α may be involved in modulating anti-tumor immunity in GBM. 
650 4 |a HIF1α 
650 4 |a hypoxia 
650 4 |a Immunosuppression 
650 4 |a TDO2 
650 4 |a Tryptophan 
700 1 |a Sadik, Ahmed  |d 1984-  |e VerfasserIn  |0 (DE-588)1207935387  |0 (DE-627)1694254747  |4 aut 
700 1 |a Tykocinski, Lars-Oliver  |d 1972-  |e VerfasserIn  |0 (DE-588)132705036  |0 (DE-627)525532420  |0 (DE-576)261192442  |4 aut 
700 1 |a Dietze, Jørn  |e VerfasserIn  |4 aut 
700 1 |a Poschet, Gernot  |e VerfasserIn  |0 (DE-588)1030300712  |0 (DE-627)735006652  |0 (DE-576)378100572  |4 aut 
700 1 |a Heiland, Ines  |d 1976-  |e VerfasserIn  |0 (DE-588)129604488  |0 (DE-627)477582079  |0 (DE-576)297744887  |4 aut 
700 1 |a Opitz, Christiane  |d 1979-  |e VerfasserIn  |0 (DE-588)132405121  |0 (DE-627)522675913  |0 (DE-576)299125041  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in immunology  |d Lausanne : Frontiers Media, 2010  |g 10(2019) Artikel-Nummer 2762, 13 Seiten  |h Online-Ressource  |w (DE-627)657998354  |w (DE-600)2606827-8  |w (DE-576)343624834  |x 1664-3224  |7 nnas  |a Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma 
773 1 8 |g volume:10  |g year:2019  |g extent:13  |a Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma 
856 4 0 |u https://doi.org/10.3389/fimmu.2019.02762  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fimmu.2019.02762/full  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200408 
993 |a Article 
994 |a 2019 
998 |g 132405121  |a Opitz, Christiane  |m 132405121:Opitz, Christiane  |d 700000  |d 721000  |e 700000PO132405121  |e 721000PO132405121  |k 0/700000/  |k 1/700000/721000/  |p 7  |y j 
998 |g 1030300712  |a Poschet, Gernot  |m 1030300712:Poschet, Gernot  |d 700000  |d 721000  |e 700000PP1030300712  |e 721000PP1030300712  |k 0/700000/  |k 1/700000/721000/  |p 5 
998 |g 132705036  |a Tykocinski, Lars-Oliver  |m 132705036:Tykocinski, Lars-Oliver  |d 910000  |d 910100  |e 910000PT132705036  |e 910100PT132705036  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1207935387  |a Sadik, Ahmed  |m 1207935387:Sadik, Ahmed  |d 140000  |e 140000PS1207935387  |k 0/140000/  |p 2 
998 |g 1181830699  |a Mohapatra, Soumya Ranjan  |m 1181830699:Mohapatra, Soumya Ranjan  |d 140000  |e 140000PM1181830699  |k 0/140000/  |p 1  |x j 
999 |a KXP-PPN1694253449  |e 3620453306 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"13 S."}],"person":[{"family":"Mohapatra","roleDisplay":"VerfasserIn","given":"Soumya Ranjan","role":"aut","display":"Mohapatra, Soumya Ranjan"},{"family":"Sadik","roleDisplay":"VerfasserIn","role":"aut","display":"Sadik, Ahmed","given":"Ahmed"},{"display":"Tykocinski, Lars-Oliver","role":"aut","given":"Lars-Oliver","family":"Tykocinski","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Dietze","display":"Dietze, Jørn","role":"aut","given":"Jørn"},{"display":"Poschet, Gernot","role":"aut","given":"Gernot","family":"Poschet","roleDisplay":"VerfasserIn"},{"display":"Heiland, Ines","role":"aut","given":"Ines","roleDisplay":"VerfasserIn","family":"Heiland"},{"roleDisplay":"VerfasserIn","family":"Opitz","display":"Opitz, Christiane","role":"aut","given":"Christiane"}],"note":["Im Titel ist alpha als griechischer Buchstabe dargestellt","Gesehen am 08.04.2020"],"origin":[{"dateIssuedDisp":"04 December 2019","dateIssuedKey":"2019"}],"relHost":[{"pubHistory":["1.2010 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"year":"2019","extent":"13","text":"10(2019) Artikel-Nummer 2762, 13 Seiten","volume":"10"},"disp":"Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastomaFrontiers in immunology","title":[{"title":"Frontiers in immunology","title_sort":"Frontiers in immunology"}],"recId":"657998354","id":{"issn":["1664-3224"],"eki":["657998354"],"zdb":["2606827-8"]},"origin":[{"dateIssuedDisp":"2010-","publisher":"Frontiers Media","dateIssuedKey":"2010","publisherPlace":"Lausanne"}],"note":["Gesehen am 07.11.13"],"physDesc":[{"extent":"Online-Ressource"}]}],"titleAlt":[{"title":"Hypoxia inducible factor 1alpha inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma"}],"id":{"eki":["1694253449"],"doi":["10.3389/fimmu.2019.02762"]},"recId":"1694253449","title":[{"title_sort":"Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma","title":"Hypoxia inducible factor 1α inhibits the expression of immunosuppressive tryptophan-2,3-dioxygenase in glioblastoma"}],"name":{"displayForm":["Soumya R. Mohapatra, Ahmed Sadik, Lars-Oliver Tykocinski, Jørn Dietze, Gernot Poschet, Ines Heiland and Christiane A. Opitz"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} 
SRT |a MOHAPATRASHYPOXIAIND0420